[ad_1]
Aspirin has long been taken by heart patients to reduce the risk of stroke and heart attack, but a new study suggests that it may also prevent cardiovascular disorders in patients with pneumonia.
Such complications are common in patients with pneumonia and strongly associated with long-term risk of death.
The study assessed whether aspirin could reduce the risk of heart attack and ischemic stroke, which is caused by blocked blood flow to the brain and accounts for about 80% of all strokes.
The researchers analyzed data from nearly 16,200 pneumonia patients across Britain. The patients were over 50 and half were aspirin users and half were not.
The primary outcome of the study was defined as having both stroke and heart attack, while either one occurring individually was defined as the secondary outcome.
The risk of having both a stroke and a heart attack was 36% lower in aspirin users than in nonusers.
Aspirin use was also associated with a 30% reduced risk of stroke alone and a 54% lower risk of heart attack alone, the results showed.
The study was due to be presented at the European Congress of Clinical Microbiology and Infectious Diseases, or ECCMID, to be held online July 9-12. Research presented at meetings should be considered preliminary until publication in a peer-reviewed journal.
“This study provides supporting evidence that the use of aspirin is associated with a reduction in ischemic events after pneumonia in a primary care setting. This drug may have a future clinical role in the prevention of this complication. important, “according to Fergus Hamilton and colleagues at the University of Bristol, Britain.
“This research really lays the groundwork for a clinical trial of aspirin in pneumonia, which remains the most common reason for hospitalization in many countries,” Hamilton said in an ECCMID press release.
More information
The American Academy of Family Physicians has more information on pneumonia.
Copyright © 2021 Health Day. All rights reserved.
Source link
